Find Academic Supervisors

• Epidemiology
• Psychiatry
• ADHD Research
• +4 more

Henrik Larsson is a Professor of Epidemiology at Örebro University's School of Medical Sciences and maintains an active affiliation with the Department of Medical Epidemiology and Biostatistics at Karolinska Institutet. His career spans advanced psychiatric epidemiological research with emphasis on ADHD, utilizing Sweden's national health registers, twin studies, and molecular epidemiology. Dr. Larsson holds a PhD in Genetic Epidemiology (2005) from Karolinska Institutet and an MA in Psychology (2001) from Örebro University. His research focuses on developmental trajectories of ADHD, genetic and environmental risk factors across the lifespan, medication effects, and comorbid conditions. His group employs sophisticated genetically-informative designs including twin and family studies to disentangle causal pathways. His publication record shows consistent focus on ADHD etiology and outcomes, with recent work expanding into cardiometabolic comorbidities, mortality risks, and transgenerational patterns. The research demonstrates ADHD medication reduces criminality and traffic accidents without increasing substance abuse risks, and reveals both continuity and change in ADHD symptoms across development. Fuller and Scott Early Career Award, Behavior Genetic Association (2013) Supervised 10+ PhD students including Zheng Chang and Qi Chen (recipients of Chinese government awards) Dr. Larsson leads research teams investigating ADHD in aging populations, nutrition-lifestyle impacts on impulsive behaviors (Eat2beNICE project), and comorbid conditions (CoCA project). His work bridges epidemiological methods with clinical applications through quality registers and randomized trials, maintaining strong connections with psychiatric clinics across Sweden.

Zheng ChangView profile

Researcher

• Pharmacoepidemiology
• Psychiatric Epidemiology
• ADHD Medication Research
• +6 more

Zheng Chang is a Principal Researcher at the Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden. He leads the Psychiatric and pharmaco-epidemiology research group, focusing on the effectiveness and safety of pharmacological treatments for psychiatric disorders using real-world data and advanced pharmacoepidemiology approaches. PhD in Epidemiology, Karolinska Institutet, 2013 MSc in Biomedicine, Karolinska Institutet, 2009 BSc in Life Science, Fudan University, 2007 Dr. Chang's research encompasses three main areas: 1) the effectiveness and safety of pharmacological treatment for psychiatric disorders, particularly psychotropic medications like antidepressants and ADHD medication; 2) the interplay between mental and physical illness, examining how mental disorders influence the management and prognosis of chronic somatic diseases; and 3) forensic psychiatry, investigating how psychiatric disorders and their treatment affect criminal behavior and recidivism. His work frequently utilizes large-scale population data from national health registers and medical claim databases across Sweden, China, and the US. His extensive publication record demonstrates a strong focus on ADHD medication research, with numerous studies examining the risks and benefits of these treatments across various outcomes including depression, cardiovascular diseases, unintentional injuries, and mortality. His more recent work has expanded into examining associations between autism and dementia across generations, sex differences in psychiatric disorders, and the interplay between mental illness and chronic physical conditions like kidney disease. Rafaelsen Young Investigator Award from the International College of Neuropsychopharmacology, 2019 COFAS Marie Curie International Postdoc Fellowship, 2014 Dr. Chang currently supervises several doctoral students including Tyra Lagerberg, Le Zhang, and Nanbo Zhu. His research has been supported by multiple funding sources including the Swedish Research Council (VR), Swedish Research Council for Health, Working Life, and Welfare (Forte), Norwegian research counsel, Karolinska Institutet Research Foundation, and Thurings Stiftelse. His work often involves international collaborations across multiple institutions and countries. As leader of the Psychiatric and pharmaco-epidemiology research group, Dr. Chang oversees a team of researchers investigating the complex relationships between mental health, physical health, and medication effects using sophisticated epidemiological methods and large population datasets.

Kia Jane RichmondView profile

Professor

• English Education
• Culturally Responsive Teaching
• Young Adult Literature
• +3 more

Dr. Kia Jane Richmond is a Professor in the English Department at Northern Michigan University, specializing in English Education, Culturally Responsive Teaching, and Young Adult Literature. With a Ph.D. in English Studies (Composition and Pedagogy) from Illinois State University and over two decades of experience, she focuses on mental health portrayals in YA fiction and pedagogical strategies for teacher training. B.A., English and Psychology, Texas Christian University (1986) M.A., English, East Texas A&M University (1997) Ph.D., English Studies, Illinois State University (2001) Her research examines how young adult literature can reduce stigma, promote empathy, and address mental health issues like depression, PTSD, and OCD. She also explores multiliteracies, disciplinary literacy, and academic service learning. Recent work includes analyzing visual literacy and literacy quadrants for pre-service teacher education. Kia has received multiple accolades, including the Stephen Young & Tricia Kinley Distinguished Faculty Award (2021) and the Charles Carpenter Fries Award (2015). She secured grants such as the NMU Faculty Research Grant (2017-18) and the MEEMIC Foundation Grant (2011). CEL English Leadership Quarterly Best Article Award (2017) Marilyn Hollinshead Visiting Scholar (2007) Community Partner of the Year (2007) She directs NMU’s English Education program and supervises student teachers across Michigan and Wisconsin. Her 2019 book, Mental Illness in Young Adult Literature , synthesizes her research on fictional portrayals of mental health.

• Clinical Psychology
• Mental Health
• Obsessive-Compulsive Disorder
• +3 more

Dr. Mairwen Jones is a Professor at the University of Sydney, where she has been employed since 1993. She has held significant roles including Acting Head of School, Deputy Head of School (Behavioral and Community Health Sciences), and Sub Dean (Graduate Coursework and Students). As a psychologist, she specializes in anxiety disorders, particularly obsessive-compulsive disorder (OCD), and leads the University of Sydney Anxiety Disorders Clinic. Her academic qualifications include a BA (Hons1) in Psychology and a PhD from the University of Sydney. Her research focuses on OCD treatment methodologies, notably Danger Ideation Reduction Therapy (DIRT), and its application across diverse populations including geriatric patients and cultural minorities. She has authored/co-authored over 50 peer-reviewed articles, two books on DIRT for OCD subtypes, and has contributed to influential texts such as the International Handbook on OCD and Encyclopedia of Psychotherapy . Dr. Jones has secured national grants including two NHMRC project grants and Rotary Mental Health grants. Her work spans clinical practice, public health, and global health initiatives, with significant contributions to HIV/AIDS mental health research in Vietnam. She is a member of key organizations including the Sydney Southeast Asia Centre, International Association of Applied Psychology, and Australian Association of Cognitive Behavioural Therapists. Awarded the Australian Psychological Society Prize and Dick Thompson Prize for academic excellence, her teaching focuses on psychopathology and supervision in higher degree research. Her research emphasizes cross-cultural mental health, stigma reduction, and innovative therapy approaches for OCD.

• Autism Spectrum Disorder
• Child Psychology
• Cognitive Behavioral Therapy
• +3 more

Sherin Stahl, PhD, is an Assistant Professor of Child Psychology at Yale University School of Medicine, affiliated with the Child Study Center and Pediatrics departments. She holds secondary appointments in Pediatrics and specializes in treating anxiety, tic disorders, OCD, and ASD. Her research focuses on autism spectrum disorder, including early diagnostic tools, emotion perception in ASD individuals, and using computerized games to enhance social skills in children with ASD. Education & Training: PhD in Clinical Psychology, University of South Florida (2002) MA in Clinical Psychology, University of South Florida (1990) AB in Psychology & English, Wellesley College (1985) Research & Clinical Focus: Dr. Stahl’s work combines clinical practice with translational research. Her studies explore ASD interventions and emotional perception deficits, while her clinical expertise spans OCD, GAD, social anxiety, and panic disorder. She has advanced certifications in behavioral therapies for tic disorders, BFRBs, and exposure-based treatments for OCD. Professional Engagement: Active member of the American Psychological Association and International OCD Foundation. She has served as a peer reviewer for the Journal of Child Abuse and Neglect . Lab & Affiliations: Affiliated with the Tic Disorder & Obsessive Compulsive Disorder Program at Yale Medicine, contributing to multidisciplinary care and research initiatives.

• Forensic Genetics
• Genomics
• Population Genetics
• +3 more

Ángel María Carracedo Álvarez is a Professor of Forensic Medicine at the University of Santiago de Compostela (USC), affiliated with the Faculty of Medicine and Dentistry and the Department of Forensic Sciences. A renowned expert in genetics and forensic medicine, he has directed the Institute of Legal Medicine since 1994 and leads the Galician Public Foundation of Genomic Medicine and the National Genotyping Center (CEGEN). His research focuses on forensic genetics, population genomics, and clinical genetics, with over 340 publications in high-impact journals like Science and Nature . He chairs the Genomic Medicine Group at USC, comprising 100+ researchers, and holds leadership roles in international organizations such as the International Society of Forensic Genetics and the Spanish Society of Pharmacogenetics. Education: Earned a Doctor of Medicine (1982) with an extraordinary thesis award from USC, focusing on erythrocyte enzyme polymorphisms in the Galician population. His work has pioneered molecular genetic techniques for forensic identification, applied globally in cases like the 11-M Madrid attacks and the 2004 Asian tsunami. Research Interests: Forensic genetics, population genomics, pharmacogenetics, and neurogenetics. His lab has become a global reference in comparative genomics and forensic identification methods. Recent work explores genomic signatures of Alzheimer’s, schizophrenia, and autism spectrum disorders. Awards: Recipient of the National Genetics Award (2015), Medal of Galicia (2011), King Jaime I Award for Medical Research, and Castelao Medal (2006). He is a member of the Royal Galician Academy of Sciences and editorial board member of Forensic Science International: Genetics . Grants & Labs: Coordinates the Genomic Medicine Group at USC, CIBERER (Rare Diseases), and the Santiago de Compostela Health Research Institute (IDIS). His teams develop diagnostic tools and therapeutic strategies in genetic disorders, leveraging multi-omics and CRISPR technologies. Labs/Teams: Leads the USC Genomic Medicine Group, CEGEN, and collaborates internationally on projects like the GR@ACE/DEGESCO dementia initiative. Recent innovations include web tools like CARTAR for CAR-T therapy target identification and forensics-related VISAGE for ancestry analysis.

• Psychiatry
• Neuropsychiatry
• Genetics
• +12 more

Ole Andreassen is a Professor at the University of Oslo and Head of the Center for Precision Psychiatry at Oslo University Hospital. He is also a Senior Consultant at Nydalen DPS, Oslo University Hospital. His research focuses on the genetic, environmental, and neurobiological mechanisms underlying brain diseases, including mental and neuropsychiatric disorders, with an emphasis on personalized psychiatry and clinical trials. His educational background includes a cand.med. from the University of Bergen (1993), a PhD (1996), and postdoctoral training at Harvard Medical School (1998–2000). He became a Specialist in Psychiatry in 2006. Andreassen’s research spans psychiatric genetics, neuroimaging (MRI), psychopharmacology, brain pathology, and the overlap between mental and physical health. He is a pioneer in precision psychiatry, utilizing large-scale genomic and neuroimaging data to understand disease mechanisms and develop targeted treatments. His work frequently involves polygenic risk scores, brain aging, immune system interactions in mental illness, and cross-disorder genetic analyses. His recent publications reveal a strong emphasis on integrating genetics with brain structure and function, exploring immune and metabolic links to psychiatric disorders, and developing computational tools for precision medicine. Themes include genetic overlap across disorders, sex differences, developmental trajectories, and the impact of environmental factors. Fridtjof Nansen Prize for Outstanding Research (2023) The Brain Council's Research Award (2024) University of Oslo Research Prize (2020) Elected Member, Norwegian Academy of Sciences and Letters (2014) Fulbright Scholarship (2011) Andreassen leads a major research center and collaborates extensively in international consortia. He has secured significant research grants and supervises a large research team, though specific student names are not listed. His work has direct implications for improving diagnosis, treatment, and prevention in psychiatry.

Connor KernsView profile

Associate Professor

• Autism Spectrum Disorder
• Anxiety disorders in children and youth
• Stress-related disorders
• +5 more

Dr. Connor Kerns is an Associate Professor in the Department of Psychology at the University of British Columbia, Faculty of Arts. She directs the Anxiety Stress and Autism Program (ASAP) lab, which focuses on understanding anxiety and stress-related disorders among individuals on the autism spectrum. Her work bridges clinical psychology and autism research, with a particular emphasis on assessment and treatment approaches tailored to autistic individuals. Education: PhD in Clinical Psychology, Temple University (2013) Dr. Kerns' research primarily focuses on the complex relationship between autism spectrum disorder (ASD) and anxiety, with particular attention to how anxiety manifests differently in autistic individuals compared to neurotypical populations. Her work examines the varied presentation and phenomenology of anxiety in autism, implications for effective anxiety measurement, and development of appropriate treatment approaches. Additionally, she investigates the understudied area of traumatic experiences in youth and young adults with autism, exploring sources and expressions of traumatic stress and developing novel measures of PTSD in this population. Her research employs clinical and community-based methodologies to estimate the frequency of anxiety and stress-related disorders among autistic individuals and identify risk factors. Analysis of Dr. Kerns' recent publications reveals a strong focus on the intersection of autism and anxiety, with particular attention to assessment challenges, treatment adaptation, and neurobiological correlates. Her work spans multiple domains including diagnostic methods, therapeutic approaches, and epidemiological studies examining comorbid conditions. A significant portion of her research addresses the need for specialized assessment tools and interventions that account for the unique presentation of anxiety in autistic individuals. Scientific Awards: Michael Smith Foundation for Health Research Scholar Award (2021) 2025 Mentorship Award by the UBC Department of Psychology Dr. Kerns is recognized for her dedication to mentoring students and fostering their development in research and clinical work. Her mentorship approach emphasizes integrity, compassion, and the translation of research into meaningful community impact. While specific grant information isn't detailed in the provided text, her research program suggests substantial funding support for studies examining anxiety in autism, including the development of assessment tools and interventions. As director of the Anxiety Stress and Autism Program (ASAP) lab, Dr. Kerns leads a team of post-doctoral researchers, graduate students, research assistants, and a lab manager. The lab engages in both clinical and community-based research, with a focus on translating research findings into practical guidelines for clinicians. The lab also maintains a strong community connection through its Community Advisory Board and public outreach initiatives like the "Autism Evidence ASAP" talk series.

Ailsa RussellView profile

Associate Professor

• Mental Health
• Autism Spectrum Disorders
• Cognitive Behavioral Therapy (CBT)
• +3 more

Ailsa Russell is an Associate Professor in the Department of Psychology at the University of Bath, and a member of the Centre for Applied Autism Research. She is a registered Clinical Psychologist with the Health & Care Professions Council (HCPC) and a BABCP-accredited CBT therapist. Ailsa leads the MSc in Applied Clinical Psychology program and specializes in understanding mental health comorbidities in autism, focusing on adapting cognitive behavioral interventions for autistic individuals. Her work contributes to UN Sustainable Development Goals related to good health and well-being. Her research interests include obsessive-compulsive disorder (OCD) in high-functioning autism, social identity and self-esteem in autism, and the mental health impacts of repetitive behaviors. She has led numerous projects funded by the National Institute for Health Research (NIHR) and NHS Trusts, including studies on guided self-help for depression in autistic adults and improving accessibility to psychological interventions. Key projects include the ADEPT trial (Autism Depression Trial), evaluating low-intensity therapies, and the Bath NIHR Mental Health Research Group, addressing service delivery challenges. Ailsa's work has been cited over 1,000 times, with notable publications on adapting CBT for autism and analyzing repetitive negative thinking in autistic populations. Her activities include training sessions on adapting CBT for autism and roles on policy committees, such as the House of Lords Special Enquiry Committee. Collaborations span clinical, academic, and governmental sectors, emphasizing real-world applications of research findings.

• Clinical Psychology
• Mental Health
• Hoarding Disorder
• +3 more

Silviya Doneva is a researcher at Norwich Medical School, University of East Anglia, specializing in clinical psychology and mental health research. She holds a Doctorate in Clinical Psychology and is actively contributing to the understanding of hoarding disorder and its co-occurring conditions. Her work is published in open-access formats, indicating a commitment to accessible science. Her research interests lie primarily in clinical psychology, with a focus on hoarding disorder, mental health comorbidities, and systematic reviews of psychological conditions. These interests are reflected in her recent scholarly output and align with the mission of clinical research at Norwich Medical School. Her recent publication trends indicate strong engagement with evidence-based mental health research, particularly in synthesizing findings on complex psychological disorders. This work contributes to diagnostic understanding and potential treatment pathways in clinical settings. Scientific Awards: No awards listed in the provided text. There is no information available about student advising or research grants in the provided material. However, her involvement in a research output suggests potential participation in funded or collaborative projects. No specific laboratory or research team is mentioned in the provided text, though her affiliation with Norwich Medical School implies integration within broader clinical psychology or mental health research networks.

• Psychiatry
• Child and Adolescent Psychiatry
• Obsessive-Compulsive Disorder
• +8 more

Euripedes C. Miguel is Professor and Chair of Child and Adolescent Psychiatry at the Department of Psychiatry, University of São Paulo School of Medicine (USP). He holds adjunct appointments as Associate Professor at the Yale Child Study Center, Yale University School of Medicine, and at the Department of Psychiatry and Behavioral Sciences, Duke University Medical Center. He also serves as Consultant in Research at Massachusetts General Hospital, Harvard Medical School. He is the Coordinator of the National Institute for Developmental Psychiatry (INPD), a leading research center focused on preventive mental health in children and adolescents. PhD, Psychiatry Department, University of São Paulo (1992) PhD, Harvard Medical School, Massachusetts General Hospital (1994) MD, University of São Paulo Medical School (1982) Dr. Miguel's research is centered on obsessive-compulsive disorder (OCD) and related conditions, with a focus on neurobiological mechanisms, clinical trajectories, and public health interventions. His work integrates neuroscience, genetics, and clinical psychiatry to understand the developmental pathways of psychopathology. He has pioneered large-scale studies on OCD, including genome-wide analyses, neuroimaging of brain circuits, and digital cognitive behavioral therapy. His research interests include: Neural circuits in OCD and anxiety disorders Biological markers of psychiatric conditions Developmental psychiatry and early intervention Multicenter clinical trials (e.g., SMART trials for pediatric OCD) Digital mental health and treatment accessibility High-risk cohort studies for psychopathology and resilience His recent publications reflect a strong trend in global collaborative research , with multicenter studies on OCD severity, brain structure, and functional connectivity. He has been instrumental in validating assessment tools like the Yale-Brown Obsessive Compulsive Scale across cultures and languages. His work increasingly emphasizes translational neuroscience and preventive strategies in child mental health. Scientific awards and recognitions include: IPq Award for best research at USP’s Institute of Psychiatry Prof. Ulysses Vianna Filho’s Award (2005, 2006) V Psychiatry Week Award OCDi AWARD from the World Congress of Psychiatry (1996) Dr. Miguel has been actively involved in securing research grants and leading national and international consortia. He founded the Obsessive-Compulsive Spectrum Disorders Program at USP (1994–2009) and continues to mentor a broad network of researchers. His collaborations include frequent co-authorship with leading experts such as James Leckman, Michael Bloch, and Thomas Fernandez at Yale. He plays a key role in advancing interdisciplinary team science in psychiatry. He leads the National Institute for Developmental Psychiatry (INPD) , which conducts longitudinal cohort studies such as the Butantã Birth Cohort and Pregnant Women Cohort, aiming to identify early markers of psychopathology and resilience. The INPD serves as a hub for training, innovation, and policy-relevant research in child mental health in Brazil and beyond.

• Child and Adolescent Psychiatry
• Tourette Syndrome
• Obsessive-Compulsive Disorder (OCD)
• +12 more

Michael H. Bloch, M.D., M.S., is an Associate Professor at the Yale Child Study Center within the Yale School of Medicine. He is the Director and Co-Founder of the Pediatric Depression Clinic and Co-Director of the Tic and OCD Program. He also serves as Associate Program Director of the Albert J. Solnit Integrated Training Program and Associate Training Director of the Child Study Center’s psychiatry residency program. Education: MD, Yale University School of Medicine (2004); MS, Chronic Disease Epidemiology, Yale University (2009); BA, Biology, University of Pennsylvania (2000) Board Certifications: Psychiatry and Child & Adolescent Psychiatry, American Board of Psychiatry and Neurology Dr. Bloch's research is centered on evidence-based treatments for childhood and adult neuropsychiatric disorders. His primary areas of interest include Tourette syndrome, OCD, trichotillomania, ADHD, depression, and anxiety . He employs clinical trials and meta-analyses to evaluate pharmacological and behavioral interventions, with a particular focus on treatment-resistant conditions and novel therapeutics such as ketamine. His recent publications demonstrate a strong trend in meta-analytic methodologies applied to pediatric psychopharmacology, including dose-response relationships of SSRIs in OCD, stimulant dosing in ADHD, and ketamine’s efficacy in adolescent depression and suicidality. His work frequently appears in high-impact journals such as The Lancet Child & Adolescent Health , Molecular Psychiatry , and the American Journal of Psychiatry . Scientific recognition includes: Samuel Ritvo Teaching Award (2024) Norbert and Charlotte Rieger Award for Scientific Achievement (2013) Seymour L. Lustman Award for Psychiatry Research (2009) Associate Member, American College of Neuropsychopharmacology NIH Loan Repayment Program Award Dr. Bloch mentors trainees through the T32 Postdoctoral Research Fellowship in Childhood Neuropsychiatric Disorders and leads NIH-funded clinical trials, including studies on ketamine for adolescent suicidality and neurofeedback for Tourette syndrome. He also serves on the editorial boards of several leading journals, including the Journal of the American Academy of Child and Adolescent Psychiatry and Depression and Anxiety . He is actively involved in the Bloch Lab , part of the Clinical Neuroscience Research Unit at Yale, focusing on translational research in neurodevelopmental and mood disorders. His team collaborates extensively with researchers such as James Leckman, Angeli Landeros-Weisenberger, and John Krystal.

• Clinical Psychology
• Cognitive Vulnerability
• Hypochondriasis
• +3 more

Sandra Arnaez Sampedro is a Lecturer at the Universitat de València, affiliated with the Faculty of Psychology and Speech Therapy and the Department of Personality, Psychological Assessment and Treatment. She is a member of the I'TOC Research and Treatment of Obsessions and Compulsions research group, where she contributes to advancing understanding and treatment of obsessive-compulsive spectrum disorders. Her research focuses on clinical psychology, particularly cognitive vulnerability to hypochondriasis and obsessive-compulsive disorders. Key areas include dysfunctional beliefs, intrusive thoughts, and psychological assessment. Her work is grounded in cognitive-behavioral frameworks, aiming to improve diagnostic accuracy and therapeutic interventions for anxiety-related conditions. The trends in her research, particularly evident from her doctoral work, emphasize cognitive mechanisms underlying health anxiety and obsessions. These studies fall within broader disciplines such as clinical psychology and cognitive science, with specific focus on intrusions, threat appraisal, and maladaptive belief systems. No scientific awards listed. She has not supervised any thesis students listed in the provided data, and there is no mention of grants or funding received. Further details on mentorship or funding activities are unavailable. Sandra is actively involved in the I'TOC research group, which specializes in the study and treatment of obsessions and compulsions, contributing to both clinical practice and empirical research in this domain.

• Clinical Psychology
• Eating Disorders (Orthorexia Nervosa)
• Emotional Regulation
• +5 more

Maddy Greville-Harris is a Senior Lecturer in Psychology and Clinical Psychologist at Bournemouth University, specializing in eating disorders, emotional regulation, and surgeon wellbeing. She completed her MSc, PhD, and Clinical Doctorate at the University of Exeter and serves as a pastoral tutor in the Psychology Department. Role : Senior Lecturer & Clinical Psychologist Education : MSc, PhD, Clinical Doctorate (University of Exeter) Her research focuses on Orthorexia Nervosa, linking emotional dysregulation and perfectionism to eating disorder risk. She develops wellbeing initiatives for surgeons and evaluates online interventions for eating disorders. Recent work includes collaborations with the Royal College of Surgeons on peer support programs. Scientific Trends : Recent publications emphasize: Emotion regulation in eating disorders Surgeon resilience and peer support DBT-informed digital interventions Sex-specific risk mechanisms Placebo/nocebo effects in pain management Her expertise bridges clinical practice and academic research.

• Cognitive Neuropsychology
• Psychosis
• Schizophrenia
• +7 more

Professor Susan Rossell is a Professor and Director of Clinical Trials at Swinburne University of Technology's School of Health Sciences and Centre for Mental Health. She also holds an adjunct position at St Vincent's Health. Her research focuses on cognitive neuropsychology, psychosis, schizophrenia, and body dysmorphic disorder, with a strong emphasis on neuroimaging and clinical trials. Her research interests span cognitive neuropsychology , psychosis , body dysmorphic disorder (BDD) , neuroimaging , and psychedelic-assisted psychotherapy . She investigates the neurobiological and cognitive underpinnings of psychiatric disorders, with a focus on treatment innovation and clinical translation. Her recent publications highlight a strong trend in novel therapeutic interventions , particularly in psychedelic-assisted therapies for treatment-resistant conditions such as schizophrenia, depression, and BDD. She also contributes to clinical guidelines, cognitive assessment tools, and methodological advancements in mental health research. Her work frequently involves large consortia like ENIGMA, reflecting a collaborative, data-driven approach. Scientific Awards: International Schizophrenia Research Young Investigator Award Young Investigator Award, Winter Workshop on Schizophrenia Research Vice Chancellors Research Excellence Award, Swinburne University International Womens Day Award: Significant Woman, Swinburne University She actively supervises numerous PhD students, focusing on topics such as speech pattern detection in mental illness , VR-based mindfulness , neuroimaging of hallucinations , and psychedelic therapies . She has secured significant grant funding from NHMRC, Wellcome Trust, Barbara Dicker Brain Science Foundation, and industry partners for projects on psilocybin , DMT , oxytocin , and digital biomarkers . She leads or contributes to several research teams and labs, including the Centre for Mental Health at Swinburne, and collaborates extensively through networks like the MAGNET Clinical Trial Network and ENIGMA Consortium .